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ABSTRACT
Recent studies showed that small interfering RNAs
(siRNAs) and Piwi-interacting RNA (piRNA) in mam-
malian germ cells play important roles in retrotrans-
poson silencing and gametogenesis. However,
subsequent contribution of those small RNAs to
early mammalian development remains poorly
understood. We investigated the expression pro-
files of small RNAs in mouse metaphase II
oocytes, 8–16-cell stage embryos, blastocysts and
the pluripotent inner cell mass (ICM) using
high-throughput pyrosequencing. Here, we show
that during pre-implantation development a major
small RNA class changes from retrotransposon-
derived small RNAs containing siRNAs and piRNAs
to zygotically synthesized microRNAs (miRNAs).
Some siRNAs and piRNAs are transiently
upregulated and directed against specific retro-
transposon classes. We also identified miRNAs
expression profiles characteristic of the ICM and
trophectoderm (TE) cells. Taken together, our
current study reveals a major reprogramming of
functional small RNAs during early mouse develop-
ment from oocyte to blastocyst.
INTRODUCTION
RNAs ranging from 19 to 32nt contain functional small
non-coding RNAs involved in gene regulation. Three
major classes of functional small RNAs have been
found: small interfering RNA (siRNA), microRNA
(miRNA) and Piwi-interacting RNA (piRNA). siRNAs
and miRNAs, with a typical length of 21–23nt, are pro-
cessed from longer transcripts forming double-strand and
stem-loop structures, respectively, by digestion with an
RNase III enzyme, Dicer, and then their single-strand
elements are incorporated into the RNA-induced silencing
complex (RISC) and function as mediators in gene
silencing (1,2). piRNAs are  25–32nt in length, speciﬁc-
ally expressed in germ line cells and associated with the
Piwi family proteins (3–6). Gene silencing involving such
small non-coding RNAs appears to play essential roles in
regulation of gene expression in development, diﬀerenti-
ation and proliferation (7–18).
Recent studies have shown that siRNAs and piRNAs
are expressed in mammalian germ cells and play import-
ant roles in retrotransposon-silencing and gametogenesis
(13,14,18). Many siRNAs, like piRNAs, appear to be
derived from repetitive sequences including retrotrans-
posons. The contribution of such small RNAs (including
miRNAs) to mammalian gametogenesis is further
validated by failures of gametogenesis in mice carrying
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associated, respectively, with piRNAs (15–17) and
siRNAs/miRNAs production (11,12).
In early development of pre-implantation mammalian
embryos, the ﬁrst transition from maternal to embryonic
(zygotic) programs takes place as early as the two-cell
stage (19), and qualitative and quantitative changes in
gene expression occur over the subsequent development.
At the blastocyst stage, when the embryo is composed of
two distinct cell populations, the inner cell mass (ICM)
and trophectoderm (TE), marked diﬀerences in gene ex-
pression between them can be detected (20,21). Although
small non-coding RNAs play key roles in gametogenesis
(13,14,18), little is known about their subsequent contri-
bution to early mammalian development. In the present
study we investigated the expression of small RNAs in
mouse unfertilized (metaphase II: MII) oocytes, 8–16-cell
stage embryos, blastocysts as well as pluripotent ICMs by
high-throughput pyrosequencing. While the recent study
presented the expression proﬁle of known miRNAs in
early mouse development (12), our current study has
revealed comprehensive proﬁles of small RNAs containing
uncharacterized small RNAs in pre-implantation
embryos. The data thus demonstrate a drastic change in
the expression of small RNAs associated with the transi-
tion from oocyte to embryo during mammalian
development.
MATERIALS AND METHODS
Collection and culture of unfertilized eggs and embryos
Female ICR mice (5–8 weeks old) were superovulated via
intraperitoneal injection of 7–10 i.u. of pregnant mare
serum gonadotropin (PMSG) and human chorionic go-
nadotropin (hCG) at 48h intervals. The female mice
were then mated with male ICR mice and inspected for
vaginal plugs the next day. Unfertilized eggs (metaphase II
eggs) were also collected from female mice without mating
at 16–20h post hCG, and subjected to treatment with
hyaluronidase (300U/ml in M2 medium). Fertilized
embryos were collected from plug-positive female mice
at the expected embryonic age as hours post-hCG:
8–16-cell stage embryo, 64–70h; blastocyst, 88–94h.
Embryos were cultured in KSOM-AA medium containing
4mg/ml BSA in a 5% CO2 humidiﬁed chamber (22).
Isolation of ICM and TE
Immunosurgery for isolation of ICM was carried out as
described previously (23,24). Brieﬂy, blastocysts were
placed in acidic Tyrode’s solution (pH 2.5) to remove
the zona pellucida and rinsed 3 times with M2 medium
(Sigma). Zona-free embryos were incubated in anti-mouse
antiserum (1:20 in M16 medium, Rockland) at 37 C for
10min in a 5% CO2 humidiﬁed chamber. The embryos
were then washed 3 times in M16 medium and incubated
in guinea pig complement (1:20 with M16 medium, MP
Biomedicals, LLC) for 30min at 37 C in a 5% CO2
humidiﬁed chamber. After incubation and washing 3
times in M16 medium, ICM was isolated from the
embryos by gentle pipetting with a glass micropipette.
Microsurgery was carried out to isolate TE populations.
Brieﬂy, zona-free blastocysts were placed in a drop of M2
medium on a plastic Petri dish, and the drop covered with
liquid paraﬃn. Excess medium was slowly removed using
a glass micropipette so that the blastocyst could be
ﬁxed on the Petri dish in a position suitable for dissection
(25). The blastocysts ﬁxed onto the dishes were equatori-
ally cleaved using a 30-G needle under a ZEISS stereo-
microscope (Stemi 2000-C). Mural TE fragments
were then collected via attachment to the tip of a 30-G
needle.
Construction of small RNA libraries from
pre-implantation mouse embryos
Small RNA libraries were constructed based on previous
protocols (26,27). Total RNA was extracted from 1470
unfertilized eggs, 960 embryos at the 8–16-cell stage, 438
blastocysts and 405 ICMs using TRIzol reagent
(Invitrogen), and subjected to size fractionation using
ﬂash PAGE (Ambion) according to the manufacturer’s
instructions. Approximately 17–40-nt RNA fragments
were collected and subjected to ligation with 5mM of the
30-adaptor RNA oligonucleotide (Linker-1), which is
50-adenylated and 30-blocked with a dideoxy-C base
(IDT, Supplementary Table S1), by T4 RNA ligase
(Amersham) without ATP at 37 C for 1h. The RNAs
were then puriﬁed by polyacrylamide gel electrophoresis,
eluted from gels in elution buﬀer (0.5M ammonium
acetate, 1mM EDTA and 0.1% SDS), collected by
ethanol precipitation and dissolved in H2O. The collected
RNAs were further ligated to the 50-adaptor RNA oligo-
nucleotide (Supplementary Table S1) by T4 RNA ligase in
the presence of ATP at 37 C for 1h, and used as templates
to synthesize the ﬁrst strand complementary DNAs
(cDNAs) using SuperScript II reverse transcriptase
(Invitrogen) with the 30 PCR Oligo (Supplementary
Table S1) complementary to the Linker-1 (30-adaptor
oligonucleotide) according to the manufacturer’s instruc-
tions. The resultant cDNAs were subjected to ampliﬁca-
tion by PCR using the ABI GeneAmp PCR system 9700
(Applied Biosystems). The thermal cycling was carried out
as follows. In the ﬁrst PCR, template and 50 PCR Oligo
and 30 PCR Oligo primers were heat denaturation at 96 C
for 1min, followed by 20 cycles of ampliﬁcation at 95 C
for 10s, 50 C for 1min and 72 C for 20s. The second
PCR was carried out using the ﬁrst PCR product and
the 2nd and 3rd PCR-F and -R primers for 8–10 cycles
of the thermal cycling proﬁle in the ﬁrst PCR. The third
PCR was carried out using the second PCR product with
eight cycles of the thermal cycling proﬁle of the second
PCR. The PCR products were puriﬁed by polyacrylamide
gel electrophoresis, and collected and dissolved in TE
(pH 8.0) as described above after every PCR
ampliﬁcation.
High-throughput sequencing analysis and annotation
of small RNAs
Sequence determination of the cDNAs prepared from
small RNAs was carried out using the 454 pyrosequencing
technology (Roche). The obtained sequence data were
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nih.gov/blast), and the sequences that perfectly matched
the mouse genome were selected for further analyses.
Annotation of the sequences was preformed as described
previously (13). Brieﬂy, to identify small RNAs corres-
ponding to various repeats such as rRNA, tRNA, retro-
transposon and DNA transposon, genomic positions of
the repeats were retrieved from the University
of California, Santa Cruz (UCSC) website (http://
hgdownload.cse.ucsc.edu/downloads.html) and compared
with the genomic positions of small RNAs. If the genomic
position of a particular small RNA overlapped with any
repeats by at least 15nt, this small RNA was considered to
be repeat-derived. Repeat names were retrieved for all
positions to which a small RNA was mapped, and if
multiple repeat names were retrieved, the class (such as
LTR/MaLR or rRNA) and subclass (such as IAP),
where applicable, were determined according to the
majority of positions. If the top two repeats had the
same number of positions, the class or subclass was not
determined. To identify small RNAs corresponding
to tRNAs, rRNAs, snRNAs, snoRNAs, scRNAs,
miRNAs, piRNAs (previously identiﬁed in adult and
neonate mouse testes and growing unfertilized eggs) and
mRNAs based on sequence similarity, the sequences of
these RNAs were extracted from the ﬂat ﬁles (sequence
and annotation ﬁles) of GenBank (ftp://ftp.ncbi.nih
.gov/genbank/) and sequences downloaded from the
following databases: tRNAs, Genomic tRNA Database
(http://lowelab.ucsc.edu/GtRNAdb); snoRNAs,
snoRNA database (http://www-snorna.biotoul.fr) and
RNA database (http://jsm-research.imb.uq.edu.au/
rnadb); piRNAs, RNA database (http://jsm-research
.imb.uq.edu.au/rnadb) and the Gene Expression
Omnibus (GEO) database (accession number: GSE7414);
miRNAs, miRBase (http://microrna.sanger.ac.uk/
sequences); mRNAs, Refseq Genes (ftp://ftp.ncbi.nih
.gov/refseq) and Ensembl Genes (http://www.ensembl
.org). Blastn searches were then performed using the
small RNA sequences determined in this study as
queries and the downloaded sequences as a database.
After the annotation of small RNA clones, small RNA
clusters were identiﬁed and characterized using in-house
programs based on our previous study (13).
We also carried out sequence determination of small
RNA cDNA libraries by means of conventional DNA
sequencing. The cDNAs prepared from 1470 MII oocytes
and438 blastocysts asdescribed above were subjected to20
cycles of ampliﬁcation followed by eight cycles of the
second-ampliﬁcation by PCR, and the resultant PCR
products were cloned into the pCR4-TOPO vector
(Invitrogen) according to the manufacturer’s instructions.
Approximately 600 and 700 colonies derived from the MII
oocyteandblastocystlibraries,respectively,wereexamined
by the ABI 3730 xl DNA Analyzer (Applied Biosystems)
followed by sequence annotation as described above.
Synthetic oligonucleotides
DNA oligonucleotides and siTrio siRNA duplexes were
obtained from Invitrogen and B-Bridge, respectively.
DNA and RNA oligonucleotide sequences synthesized
in this study are presented in Supplementary Table S1.
The siTrio negative-control (B-Bridige) was also used as
a non-silencing siRNA.
Reverse transcription (real-time) PCR
Total RNA extracted from unfertilized eggs and embryos
was subjected to concentration measurement by the
RiboGreen assay (Molecular Probes) according to the
manufacturer’s instructions. Reverse transcription
(real-time) PCR (Q-PCR) for miRNA was carried out
using the TaqMan MicroRNA assay and the ABI 7300
Real Time PCR system (Applied Biosystems) according to
the manufacturer’s instructions. The TaqMan MicroRNA
assays used (assay ID) were as follows: hsa-let-7b
(000378); hsa-let-7c (000379); hsa-let-7g (002282);
hsa-miR-16 (000391); hsa-miR-99b (000436); hsa-
miR-200c (000505); hsa-miR-210 (000512); mmu-miR-290
(000187); mmu-miR-292-3p (001054); mmu-miR-294
(001056); mmu-miR-295 (000189); mmu-miR-467b
(001671); mmu-miR-669a (001683); snoRNA135 (001230).
In the case of Q-PCR for protein-coding genes, total RNA
was subjected to ﬁrst-round cDNA synthesis using
SuperScript III reverse transcriptase (Invitrogen) and
oligo(dT) primer, and then Q-PCR was carried out using
the AB 7300 Real Time PCR System (Applied Biosystems)
with a TaqMan Universal PCR Master Mix together with
Assays-on-Demand Gene Expression products (Applied
Biosystems) or a SYBR Green PCR Master Mix
(Applied Biosystems) and with Perfect Real Time
Primers (TAKARA BIO) or designed PCR primers
(Supplementary Table S1). The Assays-on-Demand
Gene Expression products used and their assay ID were
as follows: Cdx2, Mm00432449_m1; Pou5f1 (Oct3/4),
Mm00658129_gH; Nanog, Mm02384862_gl; Gapdh,
Mm99999915_g1. The Perfect Real Time Primers
used were as follows (primer-set ID): Gapdh, MA050371;
Dicer, MA043537. For examination of the MuERVL_Mm
transcript, total RNA treated with Turbo DNase I
(Ambion) was subjected to cDNA synthesis with
oligo(dT) and semi-quantitative PCR was carried out.
Amanitin treatment
Alpha-amanitin (SIGMA-Aldrich) was used to inhibit
RNA polymerase II. Thirty 1-cell stage embryos (28h
post-hGC) were cultured in the presence or absence of
24mg/ml alpha-amanitin (28), and collected after 16h in-
cubation: the resultant embryos appeared to normally
develop to two-cell stage embryos. When total RNA was
prepared from the embryos, in vitro synthesized DsRed
mRNA was added as an external control for assessment
of RNA preparation. The isolated total RNAs were sub-
jected to reverse transcription followed by Q-PCR
analysis.
In vitro transcription
To construct GFP fusion genes, the MuERVL-Mm retro-
transposon and  -actin were ampliﬁed from cDNA
prepared from two-cell stage embryos and blastocysts
as a templates, respectively. The LINE-1 sequence in
Nucleic Acids Research, 2010,Vol.38, No. 15 5143pd2EGFP-L1 (6) was also ampliﬁed by PCR. The result-
ant PCR products were digested with XbaI and NotI, and
inserted into the phMGFP vector (Promega) treated with
the same restriction enzymes. The PCR primer sets for
ampliﬁcation of the templates for synthesis of sense- and
antisense-strand RNAs are presented in Supplementary
Table S1. We also constructed a template plasmid
encoding the DsRed gene via replacement of the SmaI–
NotI fragment carrying GFP in the phMGFP vector
with the SmaI–NotI fragment carrying DsRed, isolated
from the pDsRed-Monome-N1 vector (Clontech). The
constructed plasmids were digested with NotI and used
as templates in RNA synthesis. In vitro transcription
was carried out using a mMessage mMachine T7 ultra
kit (Ambion) according to the manufacturer’s
instructions.
Electroporation
Electroporation was carried out according to the previous
reports (29,30). Approximately 20–30 fertilized eggs
(one-cell stage) and 8–16-cell stage embryos were sub-
jected to electroporation in 30ml of HBS buﬀer [20mM
HEPES, pH 7.0–7.6 (SIGMA-ALDRICH), 150mM
NaCl] containing 2mg of tetramethylrhodamine-labeled
dextran (3000MW) (Molecular Probes) or 2–4mgo f
GFP-fusion gene mRNA together with 1mg of the
DsRed mRNA as a control. Three sets of four electric
pulses (21V for fertilized eggs and 28–30V for 8–16-cell
stage embryos; duration, 1ms; interval, 99ms) were de-
livered using an electronic pulse generator (model
CUY-21, BEX, Tokyo) with electrodes having a gap of
1mm (BEX, Tokyo) with 1-min intervals and polarity
changes between the sets of pulses. Delivery of
rhodamin-labeled dextran into the embryos was
examined by a ZEISS ﬂuorescent microscope (Axiovert
40 CFL). Embryos electroporated in the presence of the
reporter mRNAs were incubated in KSOM-AA medium
at 37 C in a 5% CO2 humidiﬁed chamber. Approximately
30min after electroporation, 5–10 live embryos were col-
lected for isolation of total RNA and the remaining
samples were further incubated. At 18h after electropor-
ation (corresponding to the two-cell and early blastocyst
stages), total RNA was isolated from 5 to 10 embryos. In
the case of suppression of Dicer, two-cell stage embryos
were electroporated in 30ml of HBS buﬀer containing 10ml
of 100mM siTrio siRNAs against Dicer (Supplementary
Table S1) under the same conditions as for fertilized
eggs. The electroporated embryos were then cultured in
KSOM-AA medium as described above. The levels of sup-
pression of Dicer were determined by Q-PCR.
Gene expression analyses under Dicer knockdown
More than 100 two-cell stage embryos were subjected
to electroporation with the siRNAs against Dicer as
described above. Three days after electroporation, total
RNA was extracted from 71 electroporated embryos,
which developed to blastocysts, and examined by the
Aﬀymetrix GeneChip Mouse Genome 430 2.0 Array
(Aﬀymetrix) followed by analyses using the GeneChip
Operating Software Program ver1.4 (Aﬀymetrix) with
default parameters (considered signiﬁcance: P < 0.005)
according to the manufacturer’s instructions. Genes pre-
senting with possibly signiﬁcant changes in their expres-
sions were further examined by Q-PCR. Total RNA was
extracted from  15–20 Dicer-knockdown embryos and
subjected to cDNA synthesis as described above, and
Q-PCR using primers indicated in Supplementary Table
S1 was carried out.
RESULTS
Small RNAs present in pre-implantation mouse embryos
To investigate small RNAs in pre-implantation mouse
embryos, we collected 960 embryos at the 8–16-cell stage
[2.5 days postcoitum (dpc)], 438 blastocysts (3.5 dpc) and
also 1470 unfertilized eggs (MII oocytes). Small RNAs
were extracted from the samples and examined by 454
pyrosequencing followed by sequence annotation. We
obtained 204080, 227157 and 244650 small RNA se-
quences completely matched the mouse genome from the
MII oocytes, 8–16-cell embryos and blastocysts, respect-
ively. The annotated small RNA sequences revealed a
marked increase in the known miRNA population and a
marked decrease in small RNAs corresponding to retro-
transposons sequences over the course of development
(Figure 1A). The size distribution of the small RNAs
revealed two peaks, one at 22nt and the other at 27–
30nt (Figure 1B–D). The most prominent peak at 22nt
was consistently present at all stages, but its major con-
stituent changed from retrotransposon- and mRNA-
derived small RNAs (MII oocyte and 8–16-cell embryo)
to miRNAs (blastocyst). The other peak at 27–30nt was
observed in MII oocytes and 8–16-cell embryos, but
hardly in blastocysts; and it enriched retrotransposon se-
quences. The data described above appear to be reprodu-
cible, because similar results have been obtained from
independent experiments by means of conventional
DNA sequencing procedures (Supplementary Figure S1).
Many of the 22-nt peak small RNAs other than
miRNAs and many of the 27–30-nt small RNAs were
mapped to the previously identiﬁed oocyte siRNA and
piRNA clusters, respectively (13,14) (Supplementary
Table S2); and new small RNA clusters were also
detected. But, the number of the small RNA clusters pro-
gressively decreased over the course of development
(Supplementary Table S2).
Small RNAs derived from retrotransposons
The cloning frequency of the retrotransposon-derived
small RNAs was decreased as a whole over the course
of development: the LINE-1 (L1)-derived small RNAs,
which constitute a major fraction in MII oocytes and
contain both putative siRNAs and piRNAs, obey this
rule (Supplementary Figure S2A and B). However, the
small RNAs derived from some retrotransposons
exhibited unique expression patterns. For example, the
frequency of small RNAs derived from a member of
the LTR/ERVL family, MERVL-Mm, showed a transient
increase at the 8–16-cell stage (Supplementary Figure S2A
5144 Nucleic Acids Research, 2010,Vol.38, No. 15and C) and the increased small RNAs were putative
siRNAs.
The frequency of small RNA derived from SINE/B1
was also initially low but increased at the 8–16-cell stage
and stayed at a similar level thereafter (Supplementary
Figure S2A). Interestingly, the SINE/B1 small RNAs in
MII oocytes comprise only putative siRNAs, but the small
RNAs increased at the 8–16-cell and blastocyst stages
appear to contain both putative siRNAs and piRNAs
(Supplementary Figure S2B). The expression proﬁles of
the Piwi family genes indicated that Mili, whose protein
can be associated with piRNAs ranging from 25 to 27nt
(3), was transiently expressed at the eight-cell stage
(Supplementary Figure S3), suggesting the possibility
that the SINE/B1 piRNAs may be associated with the
transiently expressed Mili in the embryos.
Small RNAs derived from retrotransposons mediate
gene silencing
We investigated whether the retrotransposon-derived
small RNAs play an active role in gene silencing. A
previous study demonstrated that exogenously introduced
target RNAs containing the L1 sequence were speciﬁcally
degraded in oocytes by an RNAi-dependent mechanism
(6). To examine whether a similar degradation of L1-con-
taining RNAs occur in pre-implantation embryos, in vitro
synthesized GFP RNAs carrying the L1 sequence were
introduced into fertilized one-cell and 8–16-cell embryos
Figure 1. Small RNA proﬁles in stages of early development of mouse embryos and in ICM. (A) Small RNA libraries from each stage were
examined by 454 pyrosequencing followed by assignment to RNA class as described in ‘Materials and Methods’ section. The distribution of the
RNA classes for each developmental stage is given as a percentage of the total annotated small RNAs. (B–E) Distribution of nucleotide lengths of
annotated small RNAs as in A. The number of clones matched the mouse genome for each library is indicated in parentheses.
Nucleic Acids Research, 2010,Vol.38, No. 15 5145by means of electroporation (Supplementary Figure S4A),
and degradation of the target RNAs was monitored by
real-time PCR (Q-PCR). As a result, the RNAs carrying
the L1 sequence were speciﬁcally degraded at both the
one-cell and 8–16-cell stages (Supplementary Figure
S4B), suggesting that a silencing mechanism similar to
that in oocytes may also operate in pre-implantation
embryos.
When GFP RNAs carrying the MERVL-Mm sequences
(Figure 2A) were introduced into one-cell and 8–16-cell
embryos, the level of the GFP RNAs carrying the
MERVL-Mm sense-strand sequence was markedly
decreased in the 8–16-cell embryos, and slightly reduced
in the one-cell embryos (Figure 2B and C). The GFP
RNAs with the MERVL-Mm antisense-strand sequence
was unaﬀected and slightly aﬀected in one-cell and
8–16-cell stage embryos, respectively. Thus, our data
indicate a stage-speciﬁc silencing of MERVL-Mm in
early developing mouse embryos, and the silencing is
likely dependent upon the level of the siRNAs derived
from the MERVL-Mm retrotransposon itself (Figure 2A
and Supplementary Figure S2A and C). In addition,
Dicer-knockdown embryos (Figure 3A) showed a
marked increase in the level of the MERVL-Mm tran-
script, consistently suggesting the involvement of RNAi
in the MERVL-Mm retrotransposon silencing [ref. (31),
Figure 3B].
Expression of miRNAs in mouse MII oocytes and
pre-implantation embryos
As a basis for analyzing the expression of miRNAs during
early mouse development, an appropriate control(s) is ne-
cessary in order to normalize the levels of miRNAs. We
thus examined the expression levels of snoRNA135 and the
miR-16 and -200c miRNAs, whose cloning frequencies
were essentially unchanged in our small RNA libraries,
by means of Q-PCR with equal amount ( 11ng) of
total RNAs prepared from MII oocytes, 8–16-cell
embryos and blastocysts. As a result, similar levels of ex-
pression in each of the examined small RNAs among the
samples were detected, suggesting that miR-16, miR-200c
and snoRNA135 are suitable for the control
(Supplementary Figure S5A).
The expression of the miRNAs belonging to the let-7
family and miR-290 and -467 clusters during early mouse
development was investigated by Q-PCR and normalized
to the level of the controls (miR-16, miR-200c or
snoRNA135). As shown in Supplementary Figure S5B,
similar expression proﬁles of the miRNAs normalized to
any of the controls were detected and the proﬁles were
compatible with the data of the cloning frequencies.
To investigate miRNAs during transition from
maternal to embryonic (zygotic) programs in early devel-
opment, we treated zygotes (one-cell stage embryos) with
alpha-amanitin, a RNA polymerase II inhibitor, for 16h
Figure 2. Active small RNAs derived from retrotransposons. (A) Small RNAs (19–24nt) of the plus strand (red) and minus strand (blue) matched
the MERVL-Mm retrotransposon in mouse MII oocytes and pre-implantation embryos. Hatched bar represents an insertion into the GFP 30 UTR.
(B and C) Degradation of GFP fusion mRNA carrying MERVL-Mm. The GFP, GFP-Actin, GFP-MERVL-Mm (sense), or GFP-MERVL-Mm
(antisense) mRNAs was introduced together with the DsRed mRNA as a control into 1-cell and 8–16-cell stage embryos by electroporation. After
0.5 and 18h of electroporation, total RNA was extracted from 5 to 10 embryos and the introduced mRNAs were quantiﬁed by Q-PCR. The levels of
GFP and its fusion mRNAs were normalized to those of DsRed mRNAs, and then further normalized to those obtained at 0.5h in each case [n=3;
error bars represent SEM; *P<0.05 (t-test)].
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belonging to the let-7 family (let-7b and -7g), which were
present in MII oocytes and markedly decreased during
pre-implantation development, and the miR-290 cluster
(miR-292 and -294), which were barely present in MII
oocytes and signiﬁcantly increases toward 8-cell and
blastocyst stages (see Supplementary Table S3). The
alpha-amanitin treated embryos, developed during the
16h culture into the two-cell stage, showed lower levels
of the miR-292 and -294 expressions compared with the
control embryos untreated with alpha-amanitin, in
contrast to the let-7s and miR-16, a ubiquitous miRNA,
with little diﬀerence in their levels (Supplementary Figure
S6). The data suggest that, while maternal miRNAs
reportedly decrease in two-cell stage embryos (12), the
zygotic expression of miRNAs most likely initiates as
early as the two-cell stage.
Small RNAs present in ICM
The blastocyst is composed of two distinct cell popula-
tions: the ICM and TE. The ICM cells exhibit
pluripotency and generate the embryo proper, and the
TE cells participate in the formation of the placenta
after implantation. To investigate small RNAs in the
ICM, we collected 405 ICMs from blastocysts by
immunosurgery (Supplementary Figure S5C) (23) and
prepared small RNAs. High-throughput sequencing
analysis as described above was carried out and we
obtained 195401 small RNA sequences that matched the
mouse genome (Figure 1A and E). As shown in Figure 1E,
miRNAs were the most predominant small RNA class of
the ICM as in the blastocyst proﬁle and the members of
the miR-290 cluster appeared to be expressed abundantly.
The piRNA peak was hardly detected (Figure 1E) and
22-nt putative siRNAs corresponding to retrotransposons
and other sequences occupied a small fraction. Numerous
rRNA derivatives were detected, but they were likely to be
degradation products resulting from the immunosurgery.
This is because they showed a broad distribution in the
small size range (<21nt) (Figure 1E) and were not so
abundant in the blastocyst proﬁle (Figure 1A and D).
Asymmetries in miRNA expressions between
ICM and TE
Based on the data of each miRNA in the ICM and blasto-
cyst, we estimated miRNAs exhibiting asymmetrical
expression between the ICM and TE (Supplementary
Table S3). To verify such an asymmetric distribution of
miRNAs, we collected TE cells from blastocysts by micro-
surgery (Supplementary Figure S5D), and their total
RNAs were examined by Q-PCR for the expression of
Oct3/4, Nanog (ICM marker) and Cdx2 (TE marker)
(20,24,32,33), in comparison with those from the blasto-
cyst as a control. The ratio of the expression level of either
Oct3/4 or Nanog to that of Cdx2 is substantially smaller in
the TE sample than in the blastocyst (BL) sample
Figure 3. Eﬀect of Dicer-knockdown on gene expressions in pre-implantation embryo (A) Suppression of Dicer expression by siRNA. The siRNAs
against Dicer (siDicer) or non-silencing control siRNAs (siCont.) were introduced into two-cell stage embryos (1.5 dpc) by electroporation, and total
RNA was extracted from the electroporated embryos (2.5, 3.5 and 4.5 dpc). The expression level of Dicer was examined by Q-PCR and normalized
to that of Gapdh examined as a control. The resultant level of Dicer in the presence of siDicer was further normalized to that in the presence of
siControl (siCont.) as 1 (n=3; error bars represent SEM). The data indicate that the level of Dicer mRNA in the presence of siDicer remains low
until 3.5 dpc and recovers toward normal level thereafter, suggesting that Dicer-knockdown at the RNA level appears to last until 3.5 dpc. (B)
MERVL-Mm and miR-99b expressions under Dicer-knockdown. The expression of MERVL-Mm, which appears to be regulated by endogenous
siRNAs, and miR-99b, which appears to be a zygotic miRNA, were examined by Q-PCR using the same samples as in A. Marked increase and
decrease in the levels of MERVL-Mm and miR-99b, respectively, were detected at 4.5 dpc, i.e. the eﬀect of Dicer-knockdown on the expression of
MERVL-Mm and miRNA became evident on the third day after the introduction of siDicer when the Dicer mRNA level recovered from RNAi
suppression. These suggest that there is a time lag in changes in Dicer mRNA and protein levels, and we then examined the eﬀect of Dicer-
knockdown on the stability of transcripts of interest on the third day after siDicer was introduced (4.5 dpc). (C) Inﬂuence of Dicer-knockdown on
gene expression. Electroporation with the siRNAs against Dicer (siDicer) and siControl (siCont.) and also preparation of total RNA were carried out
as in B. The expression levels of indicated genes were examined by Q-PCR and normalized to those of Gapdh as a control. The resultant expression
levels in the presence of siDicer were further normalized to those in siControl as 1. Data are averages of at least three independent experiments [error
bars represent SEM; *P<0.05 (t-test)].
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for collection of the TE sample. Using those RNA
samples, we investigated the levels of miR-99b and
miR-210 by Q-PCR followed by normalization to the
level of miR-200c as a control. The results indicated that
the relative amount of either miR-99b or miR-210 in the
TE was signiﬁcantly larger than that in the BL, suggesting
predominant expression of the miRNAs in the TE cells
(Supplementary Figure S5F).
We further selected the top twenty miRNAs in each
lineage (the ICM and TE groups) and examined their
cloning frequencies in MII oocytes, 8–16-cell embryos
and blastocysts (Figure 4B and C). As a result, while
most of the miRNAs in the TE group exhibited a
gradual increase in expression over the course of develop-
ment, many of the miRNAs in the ICM group, which
included ﬁve miR-290 cluster members, showed an
increase at the 8–16-cell stage followed by a smaller
change between the 8–16-cell and blastocyst stages.
Accordingly, the data suggest distinct diﬀerential expres-
sions of miRNAs between the ICM and TE cell lineages.
Dicer-knockdown in pre-implantation development
We wished to examine potential involvement of small
RNAs in pre-implantation development, and performed
suppression of Dicer, a key enzyme for production of
both siRNAs and miRNAs in gene silencing, by means
of electroporation using siRNAs against Dicer (Figure
3). Expression proﬁles in pre-implantation mouse
embryos with Dicer knockdown indicated marked
increase in the level of MERVL-Mm and also the reduc-
tion of the levels of several genes including miR-99b
(Figure 3B). Interestingly, Q-PCR conﬁrmed the signiﬁ-
cant reduction of the expression of N-myc, which appears
Figure 4. miRNA proﬁles in pre-implantation mouse embryos. (A) Major miRNAs present in MII oocytes and pre-implantation embryos for the 40
most highly expressed miRNAs based on cloning frequencies. (B and C) Proﬁles of miRNAs abundant in ICM or TE. The 20 miRNAs in each of
ICM (ICM group) (B) and TE (TE group) (C) were selected with the ratios of miRNAs (ICM/Blastocyst) (see Supplementary Table S3) and plotted
for three stages from MII oocyte to blastocyst. The members belonging to the miR-290 cluster are indicated in green.
5148 Nucleic Acids Research, 2010,Vol.38, No. 15to be associated with pluripotency, in Dicer-knockdown
embryos (Figure 3C).
DISCUSSION
Maternal and zygotic siRNAs and piRNAs in
pre-implantation mouse embryos
Endogenous siRNAs and piRNAs in mammalian germ
cells play essential roles in retrotransposon silencing
and gametogenesis (13,14,18). Our current study has
investigated subsequent contribution of such small
RNAs to early development of pre-implantation mouse
embryos. Our data revealed that, some siRNAs and
piRNAs derived from retrotransposons are transiently
(zygotically) upregulated and likely directed against
speciﬁc retrotransposons, although siRNAs and piRNAs
as a whole are markedly decreased over the course of
development (Figure 1, Supplementary Figure S2 and
Table S2).
The transient increase in the MERVL-Mm small RNAs
represents a new production, and most of the small RNAs
are putative siRNAs. Since previous studies indicated that
sense and antisense MERVL-Mm transcripts were abun-
dantly expressed at the two-cell stage, but not at other
stages (34,35), and since the MERVL-Mm transcript
was signiﬁcantly increased in Dicer-knockdown mouse
embryos (Figure 3B) (31), our present evidence strongly
suggests that endogenous siRNAs are zygotically
produced from the MERVL-Mm transcripts following
fertilization and work as mediators in RNAi-dependent
silencing directed against the MERVL-Mm transcript
itself. As a result, the level of MERVL-Mm is reduced
after the two-cell stage. Thus, an autonomous suppression
of MERVL-Mm via RNAi appears to occur.
The transiently increased piRNAs and siRNAs, which
are derived from SINE/B1, together with the increased
Mili at the same stage might also participate in autono-
mous suppression of the SINE/B1 retrotransposon.
In addition to zygotically produced siRNAs and
piRNAs, maternally-derived small RNAs may also con-
tribute to the early development. For example, it is note-
worthy that maternally derived L1 small RNAs appear to
work to at least the 8–16-cell stage, although the small
RNAs are markedly decreased following fertilization
(Supplementary Figure S2A and B). Given that genome-
wide reprogramming including protamine/histone
exchange and DNA demethylation takes place in early
mammalian development (36–38), maternally and zygot-
ically produced siRNAs and piRNAs presumably partici-
pate in the defense against harmful retrotransposons
activated during the reprogramming, which are presum-
ably silenced by chromatin modiﬁcations such as DNA
methylation in somatic cells.
Expression of miRNAs in pre-implantation mouse
embryos
MiRNAs play essential roles in gene regulation during
early development (7–9). Various mouse miRNAs are
synthesized after fertilization and the miRNA complexity
rapidly increases (Figures 1 and 4A, Supplementary
Figure S5B, S6 and Table S3). An increase in miRNAs
of the miR-290 cluster, which are speciﬁcally expressed in
embryonic stem (ES) cells (39–41), is particularly remark-
able (Figure 4A), as previously described (12). In the ICM,
miRNA is also the most predominant small RNA class as
in the blastocyst proﬁle and the members of the miR-290
cluster are expressed abundantly. Based on the expression
ratio of each miRNA in the ICM and blastocyst, we
estimated miRNAs exhibiting asymmetrical distribution
between the ICM and TE (Supplementary Table S3),
and the biased presence of some of the miRNAs was
veriﬁed using dissected TE samples (Supplementary
Figure S5F). The data suggest that diﬀerence in miRNA
expression occurs between the ICM and TE cell lineages,
which may contribute to specialization of cells in the two
cell lineages, and maintenance of stemness speciﬁcally in
the ICM cell lineage. To elucidate such contributions,
more extensive studies need to be carried out.
Potential involvement of small RNAs in pre-implantation
development
It should be noted that the expression of N-myc is sig-
niﬁcantly decreased in Dicer-knockdown embryos
(Figure 3C), although the N-myc gene regulation
involving functional small RNAs produced by Dicer
remains to be investigated. N-myc is reported to be
involved in maintenance of stemness in ES cells (42,43),
and its expression is reduced after diﬀerentiation of the
cells (44,45). N-myc is also predominantly expressed in
the ICM cells at the blastocyst stage (46). As for the as-
sociation of Dicer with pluripotency, Dicer-deﬁcient mice
are lethal at embryonic day 7.5, lacking pluripotent cells
(47). Since our Dicer knockdown was carried out in
pre-implantation embryos, the gene silencing involving
Dicer may contribute to the maintenance of stemness
even before implantation, and N-myc might play a key
role in such maintenance of stemness. Taken together,
the data suggest the possibility that the gene silencing
may participate in the maintenance and diﬀerentiation
of pluripotent cells in addition to the suppression of retro-
transposons over the course of pre- and post-implantation
development.
Transition of a major small RNA from siRNA/piRNA to
miRNA during pre-implantation development
Together with the ﬁndings of recent studies (3,5,6,12–14),
our current study has revealed that the transition of a
major small RNA class from siRNA/piRNA to miRNA
takes place during pre-implantation development (Figure
5). The data further suggest that the zygotic expression of
miRNAs as the beginning of the transition presumably
starts as early as the two-cell stage. Given that miRNA
is a major mediator of gene regulation, and predominantly
present in mammalian somatic cells including pluripotent
ES cells (40,48,49), it is conceivable that early mammalian
embryos shape the somatic type small RNA modality
and gene regulation involving miRNAs prior to their
implantation.
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